CT pulmonary angiography helps detect right heart strain in pulmonary embolism, reveals research
The study, “Assessing the role of Computed Tomography Pulmonary Angiogram in diagnosing right heart strain related to acute pulmonary embolism,” was carried out by Sean Landers, James O’Regan, Roisin Rynne, Michael M. Maher, Ronan Curtin, Deirdre Doyle, and Desmond M. Murphy in The Open Respiratory Medicine Journal.
A review of 656 patients at an Irish university hospital found that CT scans and blood tests are useful but imperfect at spotting strain on the heart in patients with a blood clot in the lung. Roughly one in five patients whose CT scan showed no sign of heart strain still had it on an echocardiogram. The authors therefore suggest that anyone diagnosed with a clinically significant pulmonary embolism should be considered for an echocardiogram, whatever the CT shows.
Why Heart Strain Matters in Lung Clots
A pulmonary embolism (PE) is a blood clot that blocks arteries in the lungs. The most serious danger is that the right side of the heart, which pumps blood into the lungs, becomes overloaded and begins to fail. Right ventricular failure is the leading cause of death in PE, and PE is the third most common cause of cardiovascular death in the United States. Heart strain can be present even when a patient’s blood pressure is stable, so it can be missed. The standard way to check is a transthoracic echocardiogram (TTE), an ultrasound scan of the heart, but it is not always available out of hours. Doctors often rely instead on the CT scan used to diagnose the clot (CTPA) and on blood tests for troponin and NT-proBNP. This study asked how well those tools predict heart strain compared with echocardiography.
What the Study Found
The team reviewed the records of all adults who had a CTPA for suspected PE over six months at Cork University Hospital in 2023. Of 656 scans, 128 (19.5 percent) showed an acute PE. Among those with a PE, 31 had heart strain reported on CT, and 25 of them also had an echocardiogram, which confirmed strain in 16 (64 percent). Of the 97 PE patients with no strain reported on CT, 39 had an echocardiogram, and 7 (17.9 percent) of those showed strain. Overall, 36 percent of PE patients who had an echocardiogram had heart strain. Compared with echocardiography, CT had a sensitivity of 69.6 percent and a specificity of 78 percent. NT-proBNP, at a 300 cut-off, was very good at catching strain (92.9 percent sensitivity) but poor at ruling it out (33.3 percent specificity). Troponin at the lab’s usual cut-off had 75 percent sensitivity and 58 percent specificity, and at a higher cut-off of 100 ng/L it had 61.9 percent and 80 percent. The differences in sensitivity between the three tests were not statistically significant. The scans were also valuable beyond the clot itself. About 70 percent of scans either found a PE or showed another likely cause of the patient’s symptoms, such as infection, fluid overload, or new cancer. Six months later, 18.8 percent of PE patients and 17.8 percent of patients without PE had died, with no significant difference.
What It Means for Patients and Clinicians
The authors conclude that CT and blood tests are quick, readily available signals of heart involvement but do not match the reliability of echocardiography. They note that the 2019 European guidelines already recommend assessing the right ventricle with an echocardiogram or biomarkers in all PE patients, regardless of risk score. This is important because treatment and monitoring depend on how severe the PE is. The authors point out the limits of their work. It was retrospective and carried out at a single hospital. Sicker patients were more likely to get an echocardiogram, which may bias the results. The troponin, NT-proBNP, and CT comparisons involved different numbers of patients, so they cannot be compared directly and may not represent all PE patients. Larger, multicentre, prospective studies are needed to confirm the findings. The study was led by corresponding author Dr. Sean Landers of the Department of Respiratory Medicine, Cork University Hospital, Cork, Ireland. Co-authors are James O’Regan, Roisin Rynne, and Desmond M. Murphy (Respiratory Medicine), Michael M. Maher and Deirdre Doyle (Radiology), and Ronan Curtin (Cardiology), all at Cork University Hospital.
Reference:
Sean Landers, James O’Regan, Roisin Rynne, Assessing the role of Computed Tomography Pulmonary Angiogram in diagnosing right heart strain related to acute pulmonary embolism, The Open Respiratory Medicine Journal, DOI: 10.2174/0118743064508829261003170120
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.